NCT06924359View on ClinicalTrials.gov

Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Alzheimer's Disease (AD)
Interventions
DIAGNOSTIC_TEST

Multimodal Ophthalmic Imaging and plasma biomarker

Multimodal Ophthalmic Imaging and plasma biomarkers (Aβ42/40, p-tau181, p-tau217, NfL and GFAP）.

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER